The Exosome Diagnostic and Therapeutics market is expected to grow at a CAGR of 29.0% during the forecasted period.
Exosomes play a key role in facilitating cell-to-cell communication in the cancer prognosis. It suppresses the immune function by inducing apoptosis of activated cytotoxic T cells, which enable tumor progression in the human body. In addition, exosomes also stimulate the angiogenesis and migration leading to metastasis. Moreover, exosomes trigger apoptosis in anti-tumor immune cells through tumor necrosis factor pathways. remarkable technological advancements in the exosome isolation kits and reagents to provide advanced extraction procedures from the body fluids.
Increasing chronic diseases, technological advancements, rising emphasis on early diagnosis of cancer, are some of the key major factors for the growth of exosome diagnostic and therapeutics market worldwide.
Global Exosome Diagnostic and Therapeutics market is segregated on the basis of application as therapeutic application and diagnostic application. Based on product type, the global Exosome Diagnostic and Therapeutics market is segmented in reagents, software and instruments. The report also bifurcates global Exosome Diagnostic and Therapeutics market based on end user in hospitals, cancer institutes, diagnostic centers and others.
Global Exosome Diagnostic and Therapeutics market report provides geographic analysis covering regions such as North America, Europe, Asia Pacific, and Rest of World. The Exosome Diagnostic and Therapeutics market for each region is further segmented for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Competitive Rivalry
System Biosciences, Inc., NX Pharmagen, Exiqon A/S are among the major players in the global Exosome Diagnostic and Therapeutics market share. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Exosome Diagnostic and Therapeutics Market has been segmented as below:
Exosome Diagnostic and Therapeutics Market, by Application
Exosome Diagnostic and Therapeutics Market, by Product Type
Exosome Diagnostic and Therapeutics Market, by End User
Exosome Diagnostic and Therapeutics Market, By Region
The report covers:
Report scope:
Global Exosome Diagnostic and Therapeutics market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Exosome Diagnostic and Therapeutics market share. Major industry players with significant revenue share include Sistemic Ltd., NX Pharmagen, Exiqun A/S, Immune Therapy Holdings AB etc.
Reasons to Buy this Report:
Customization:
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Genital Herpes Treatment Market
Hepatitis B Diagnostic Tests Market
Medication Management System Market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.2.1. Technological advancements
4.2.2. Innovative and advanced applications of exosome
4.2.3. Increasing chronic diseases
4.3. Restraints
4.3.1. Stringent government regulations
4.3.2. Lack of skilled professionals
5. Exosome Diagnostic and Therapeutics Market, By Application
5.1. Key Points
5.2. Therapeutic Application
5.3. Diagnostic Application
6. Exosome Diagnostic and Therapeutics Market, By Product Type
6.1. Key Points
6.2. Reagents
6.3. Software
6.4. Instruments
7. Exosome Diagnostic and Therapeutics Market, By End User
7.1. Key Points
7.2. Hospitals
7.3. Cancer Institutes
7.4. Diagnostic centers
7.5. Others
8. Competitive Landscape
8.1. Introduction
8.2. Recent Developments
8.2.1. Mergers &Acquisitions
8.2.2. New Product Developments
8.2.3. Portfolio/Production Capacity Expansions
8.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
8.2.5. Others
9. Company Profile
9.1. Nanosomix, Inc.
9.1.1. Company Overview
9.1.2. Product/Service Landscape
9.1.3. Financial Overview
9.1.4. Recent Developments
9.2. System Biosciences, Inc.
9.2.1. Company Overview
9.2.2. Product/Service Landscape
9.2.3. Financial Overview
9.2.4. Recent Developments
9.3. Thermo Fisher Scientific, Inc.
9.3.1. Company Overview
9.3.2. Product/Service Landscape
9.3.3. Financial Overview
9.3.4. Recent Developments
9.4. NX Pharmagen
9.4.1. Company Overview
9.4.2. Product/Service Landscape
9.4.3. Financial Overview
9.4.4. Recent Developments
9.5. Exiqun A/S
9.5.1. Company Overview
9.5.2. Product/Service Landscape
9.5.3. Financial Overview
9.5.4. Recent Developments
9.6. Sistemic Ltd.
9.6.1. Company Overview
9.6.2. Product/Service Landscape
9.6.3. Financial Overview
9.6.4. Recent Developments
9.7. Malvern Instruments Ltd.
9.7.1. Company Overview
9.7.2. Product/Service Landscape
9.7.3. Financial Overview
9.7.4. Recent Developments
The Exosome Diagnostic and Therapeutics Market has been segmented as below:
Exosome Diagnostic and Therapeutics Market, by Application
Exosome Diagnostic and Therapeutics Market, by Product Type
Exosome Diagnostic and Therapeutics Market, by End User
Exosome Diagnostic and Therapeutics Market, By Region
